eNauka - pregled
Pregled prema Projekat Puma Biotechnology Inc.
Prikaz rezultata 1 do 2 od 2
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2019 | Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial | Delaloge, Suzette; ...; Filipovic, Sladjana; ...; (broj, koautora 28) | Naučni članak | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |
| 2019 | HER-Seq: A blood-based genomic screening study to identify HER2 mutation-positive patients for enrollment into clinical trials with the pan-HER inhibitor neratinib | Tomasevic, Zoran M; Smyth, LM; Saura, C; Boni, V; Garcia-Saenz, JA; Prat, A; Eli, L; Garza, SJ; Lalani, AS; Crown, JP | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |